From: Chemotherapy near the end of life: a retrospective single-centre analysis of patients’ charts
N = 119
Last 4 weeks
Last 2 weeks
New chemotherapy
8 (6.7%)
2 (1.7%)
Ongoing chemotherapy
6 (5%)
7 (5.9%)
Total
14 (11.7%)
9 (7.6%)